Encompass Health (EHC) Stock Forecast & Price Target

$91.64

+1.00 (+1.10%)

(As of 07/26/2024 ET)

Encompass Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 10 Analyst Ratings

Based on 10 Wall Street analysts who have issued ratings for Encompass Health in the last 12 months, the stock has a consensus rating of "Buy." Out of the 10 analysts, 8 have given a buy rating, and 2 have given a strong buy rating for EHC.

Consensus Price Target

$96.50
5.30% Upside

High Forecast	$113.00
Average Forecast	$96.50
Low Forecast	$80.00

According to the 10 analysts' twelve-month price targets for Encompass Health, the average price target is $96.50. The highest price target for EHC is $113.00, while the lowest price target for EHC is $80.00. The average price target represents a forecasted upside of 5.30% from the current price of $91.64.

Type	Current Forecast 7/27/23 to 7/26/24	1 Month Ago 6/27/23 to 6/26/24	3 Months Ago 4/28/23 to 4/27/24	1 Year Ago 7/27/22 to 7/27/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	5 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$96.50	$93.29	$86.56	$71.64
Forecasted Upside	5.30% Upside	16.19% Upside	16.20% Upside	20.21% Upside

Get Encompass Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

Ad American Hartford Gold Group

Prepare for a Recession Unlike Any Other

Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.

GET THE FREE GUIDE

EHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Encompass Health Stock vs. The Competition

Type	Encompass Health	Medical Companies	S&P 500
Consensus Rating Score	3.20	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	6.45% Upside	2,827.77% Upside	10.57% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/15/2024	Truist Financial 1 of 5 stars		Boost Target	Buy ➝ Buy	$95.00 ➝ $100.00	+14.97%
7/10/2024	Barclays 2 of 5 stars		Boost Target	Overweight ➝ Overweight	$108.00 ➝ $113.00	+33.30%
7/10/2024	Leerink Partnrs 0 of 5 stars	W. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/10/2024	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$100.00	+19.09%
6/5/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$94.00 ➝ $94.00	+10.15%
5/22/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$83.00 ➝ $95.00	+11.06%
Get the Latest News and Ratings for EHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.
4/26/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Strong-Buy ➝ Strong-Buy	$85.00 ➝ $95.00	+14.89%
4/25/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$93.00 ➝ $95.00	+14.85%
2/7/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Haase Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
8/4/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$76.00 ➝ $80.00	+13.35%
5/1/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$70.00 ➝ $73.00	+12.50%
4/28/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$69.00 ➝ $74.00	+16.65%
2/8/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$68.00 ➝ $73.00	+24.00%
8/4/2022	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$83.00 ➝ $65.00	+23.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:13 PM ET.

EHC Forecast - Frequently Asked Questions

What is Encompass Health's forecast for 2024?: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Encompass Health is $96.50, with a high forecast of $113.00 and a low forecast of $80.00.
Should I buy or sell Encompass Health stock right now?: 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EHC shares.
Does Encompass Health's stock price have much upside?: According to analysts, Encompass Health's stock has a predicted upside of 16.51% based on their 12-month stock forecasts.
Has Encompass Health been upgraded by Wall Street analysts recently?: Over the previous 90 days, Encompass Health's stock had 1 upgrade by analysts.
What analysts cover Encompass Health?: Encompass Health has been rated by research analysts at Barclays, Leerink Partnrs, Royal Bank of Canada, Stephens, SVB Leerink, and Truist Financial in the past 90 days.
Do Wall Street analysts like Encompass Health more than its competitors?: Analysts like Encompass Health more than other "medical" companies. The consensus rating for Encompass Health is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EHC compares to other companies.